Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 1.00 |
| ▸ | KDM1A | O60341 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 5/20 | 0.91 |
| ▸ | RAD52 | P43351 | 5/20 | 0.91 |
| ▸ | LMNA | P02545 | 4/20 | 0.91 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.91 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.91 |
| ▸ | POLB | P06746 | 1/20 | 0.91 |
| ▸ | GAA | P10253 | 1/20 | 0.91 |
| ▸ | TRPC5 | Q9UL62 | 1/20 | 0.91 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.89 |
| ▸ | RAC1 | P63000 | 2/20 | 0.89 |
| ▸ | ACHE | P22303 | 7/20 | 0.87 |
| ▸ | MAOB | P27338 | 1/20 | 0.87 |
| ▸ | EP300 | Q09472 | 6/20 | 0.83 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.83 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.83 |
| ▸ | APP | P05067 | 1/20 | 0.80 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Columbamine SCHEMBL29395690 | 1.00 | CYP3A4 (1.00) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Columbamine SCHEMBL3324164 | 0.99 | CYP3A4 (0.98) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Jatrorrhizine SCHEMBL564128 | 0.95 | CYP3A4 (1.00) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Jatrorrhizine SCHEMBL29368316 | 0.95 | CYP3A4 (1.00) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Jatrorrhizine SCHEMBL29381269 | 0.95 | CYP3A4 (1.00) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Jatrorrhizine SCHEMBL31238510 | 0.94 | CYP3A4 (0.98) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Jatrorrhizine SCHEMBL21809027 | 0.94 | CYP3A4 (0.98) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Jatrorrhizine SCHEMBL1427435 | 0.94 | CYP3A4 (0.98) | CYP3A4KDM1AMAPTRAD52LMNA | |
| SCHEMBL2742479 | 0.94 | RAC1 (1.00) | CYP3A4KDM1AMAPTRAD52LMNA | |
| Columbamine SCHEMBL8858971 | 0.94 | CYP3A4 (0.88) | CYP3A4KDM1AMAPTRAD52LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 486 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687856-A2 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS Therapeutics, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| WO-2024229159-A2 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS THERAPEUTICS, LLC (US) | 2024-11-07 | — | — | WO | claimed |
| US-20240366525-A1 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS THERAPEUTICS, LLC | 2024-11-07 | — | — | US | claimed |
| WO-2024197225-A1 | REDOX ACTIVE ANTIFOULING COATINGS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-09-26 | — | — | WO | claimed |
| US-20230172916-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | ELEONOR (BE) | 2023-06-08 | — | — | US | claimed |
| EP-4135666-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | Eleonor (BE) | 2023-02-22 | — | — | EP | claimed |
| EP-3954371-A1 | ANTI-ACETYLCHOLINESTERASE ACTIVE COMPOSITION IN CAULIS MAHONIAE AND SCREENING METHOD THEREFOR AND APPLICATION THEREOF | Shenzhen Institute for Drug Control (Shenzhen Testing Center of Medical Devices) (CN) | 2022-02-16 | — | — | EP | claimed |
| WO-2021209623-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | ELEONOR SPRL (BE) | 2021-10-21 | — | — | WO | claimed |
| US-20200230118-A1 | USE OF BERBERINE OR ACTIVE METABOLITE THEREOF IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING PHENYLKETONURIA | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2020-07-23 | — | — | US | claimed |
| EP-3672575-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND ITS PRODUCTION PROCESS | Eleonor SPRL (BE) | 2020-07-01 | — | — | EP | claimed |
| WO-2006091676-A2 | MODULATING PLANT ALKALOIDS | CERES INC. (US) | 2006-08-31 | — | — | WO | claimed |
| CN-1725991-A | Delivery of peroxide producing enzymes to the vagina | KIMBERLY CLARK CO (US) | 2006-01-25 | — | — | CN | claimed |
| EP-1578317-A2 | DELIVERY OF PEROXIDE-GENERATING ENZYMES TO THE VAGINAL TRACT | Kimberly-Clark Worldwide, Inc. (US) | 2005-09-28 | — | — | EP | claimed |
| CN-1190425-C | Six kinds of isoquinoline alkaloid | SHANGHAI MEDICINE INST CHINESE (CN) | 2005-02-23 | — | — | CN | claimed |
| WO-2004060272-A2 | DELIVERY OF PEROXIDE-GENERATING ENZYMES TO THE VAGINAL TRACT | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2004-07-22 | — | — | WO | claimed |
| US-20040126369-A1 | Delivery of peroxide-generating enzymes to the vaginal tract | KIMBERLY-CLARK WORLDWIDE, INC. | 2004-07-01 | — | — | US | claimed |
| US-20040091556-A1 | Nasal irrigation solutions and methods of using same | TIGUNAIT RAJMANI (US) | 2004-05-13 | — | — | US | claimed |
| WO-2004011017-A1 | NASAL IRRIGATION SOLUTIONS AND METHODS OF USING SAME | HIMALAYAN INTERNATIONAL INSTITUTE OF YOGA SCIENCE AND PHILOSOPHY (US) | 2004-02-05 | — | — | WO | claimed |
| CN-1314347-A | Six kinds of isoquinoline alkaloid | SHANGHAI MEDICINE INST CHINESE (CN) | 2001-09-26 | — | — | CN | claimed |
| WO-2001007034-A1 | MULTIDRUG RESISTANCE PUMP INHIBITORS AND USES THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2001-02-01 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230172916-A1 | COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME | MANBA, CROCC, MAN2A1 | CYP3A4 1385/4885KDM1A 4875/4885MAPT 1504/4885 |
| US-20200230118-A1 | USE OF BERBERINE OR ACTIVE METABOLITE THEREOF IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING PHENYLKETONURIA | PAH, BCKDK, BHMT | CYP3A4 215/4885KDM1A 1460/4885MAPT 1424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.